Please assess the completion status of the following clinical trial:

Trial Title: Mass Drug Administration of Dihydroartemisinin-piperaquine + Single Low-dose Primaquine to Accelerate Toward Elimination Activities

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age ≥3 months~* Willingness to comply with trial procedures and written informed consent to be obtained at the beginning of the study~Exclusion Criteria:~* Severe illness or self-reported chronic illness (e.g., HIV, tuberculosis, heart/liver/kidney disease, and severe malnutrition)~* Known hypersensitivity to study drug~Additional exclusion criteria for DHA-PPQ:~* First trimester pregnancy assessed by history and/or urine pregnancy testing~* Concurrent artemisinin-based combination therapy (ACT) use~* Taking drugs that influence cardiac function or prolong QTc interval~Additional exclusion criteria for PQ:~* Pregnancy (any trimester) or currently breastfeeding an infant \<6 months of age assessed by history and/or urine pregnancy testing~* \<2 years of age

- Gender: ALL
- Minimum Age: 3 Months
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- MDA with DHA-PPQ + SLD-PQ (Type: EXPERIMENTAL): Participants in intervention villages will be given three rounds of MDA with DHA-PPQ and SLD-PQ. Prior to the intervention, participants will have received piperonyl butoxide (PBO) treated LLINs and proactive community case management. Unlike control villages, MDA-randomized villages will not receive SMC.
- Standard malaria control interventions (Type: NO_INTERVENTION): Participants in the control villages will receive standard malaria control interventions as implemented by the Senegal PNLP. This will include the distribution of PBO LLINs, proactive case management, and SMC.

Based on this trial design, predict the completion outcome and termination type (if applicable).